Suppr超能文献

使用聚合物包封细胞直接进行去污剂稳定的 G 蛋白偶联受体的分子进化。

Direct molecular evolution of detergent-stable G protein-coupled receptors using polymer encapsulated cells.

机构信息

Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zürich, Switzerland.

出版信息

J Mol Biol. 2013 Feb 8;425(3):662-77. doi: 10.1016/j.jmb.2012.11.015. Epub 2012 Nov 16.

Abstract

G protein-coupled receptors (GPCRs) are the largest class of pharmaceutical protein targets, yet drug development is encumbered by a lack of information about their molecular structure and conformational dynamics. Most mechanistic and structural studies as well as in vitro drug screening with purified receptors require detergent solubilization of the GPCR, but typically, these proteins exhibit only low stability in detergent micelles. We have developed the first directed evolution method that allows the direct selection of GPCRs stable in a chosen detergent from libraries containing over 100 million individual variants. The crucial concept was to encapsulate single Escherichia coli cells of a library, each expressing a different GPCR variant, to form detergent-resistant, semipermeable nano-containers. Unlike naked cells, these containers are not dissolved by detergents, allowing us to solubilize the GPCR proteins in situ while maintaining an association with the protein's genetic information, a prerequisite for directed evolution. The pore size was controlled to permit GPCR ligands to permeate but the solubilized receptor to remain within the nanocapsules. Fluorescently labeled ligands were used to bind to those GPCR variants inside the nano-containers that remained active in the detergent tested. With the use of fluorescence-activated cell sorting, detergent-stable mutants derived from two different family A GPCRs could be identified, some with the highest stability reported in short-chain detergents. In principle, this method (named cellular high-throughput encapsulation, solubilization and screening) is not limited to engineering stabilized GPCRs but could be used to stabilize other proteins for biochemical and structural studies.

摘要

G 蛋白偶联受体(GPCRs)是最大的一类药物蛋白靶标,但由于缺乏对其分子结构和构象动力学的信息,药物开发受到了阻碍。大多数机制和结构研究以及用纯化受体进行的体外药物筛选都需要用去污剂溶解 GPCR,但通常情况下,这些蛋白质在去污剂胶束中只有较低的稳定性。我们开发了第一种定向进化方法,该方法允许从包含超过 1 亿个变体的文库中直接选择在选定的去污剂中稳定的 GPCR。关键概念是将文库中的单个大肠杆菌细胞包裹起来,每个细胞表达不同的 GPCR 变体,形成耐去污剂的半透纳米容器。与裸细胞不同,这些容器不会被去污剂溶解,这使我们能够在原位溶解 GPCR 蛋白,同时保持与蛋白质遗传信息的关联,这是定向进化的前提。孔的大小可以控制,以允许 GPCR 配体渗透,但溶解的受体仍留在纳米胶囊内。用荧光标记的配体与那些在测试的去污剂中仍然保持活性的纳米容器内的 GPCR 变体结合。通过使用荧光激活细胞分选,可以鉴定出两种不同的 A 家族 GPCR 衍生的稳定去污剂突变体,其中一些在短链去污剂中的稳定性最高。原则上,这种方法(称为细胞高通量封装、溶解和筛选)不仅限于工程稳定 GPCR,还可以用于稳定其他蛋白质进行生化和结构研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验